Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1470 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GW Pharma initiates Cannabinoids Phase IIa trial

The study programme follows pre-clinical research results and comprises at least three small scale clinical trials evaluating various metabolic parameters. The first Phase IIa study to commence is

Asterand signs $24.3m contract with NCI

The base award is valued at $5.4m over 17 months; with provisions for renewal at the NCI’s option. The contract is partly funded by the American Recovery and

Mylan Pharma introduces generic Wellbutrin XL tablets

Wellbutrin XL (bupropion hydrochloride) is an antidepressant of the aminoketone class and is chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor, or other known antidepressant agents. Wellbutrin

3-V Biosciences names new CEO

Most recently, Parsey worked at Genentech, a member of the Roche Group as the senior group medical director in Genentech Research and Early Development, overseeing early clinical development